No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs372930528 |
chr12:50746271-50746272 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs545688941 |
chr12:50746283-50746284 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs189990959 |
chr12:50746312-50746313 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs71459098 |
chr12:50746320-50746321 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs7304951 |
chr12:50746348-50746349 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs199626368 |
chr12:50746352-50746353 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs550883696 |
chr12:50746360-50746361 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs567893686 |
chr12:50746362-50746363 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs76768594 |
chr12:50746372-50746373 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs562275454 |
chr12:50746410-50746411 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs546296194 |
chr12:50746424-50746425 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs566094479 |
chr12:50746434-50746435 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs529495499 |
chr12:50746477-50746478 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs71466905 |
chr12:50746514-50746515 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs538228487 |
chr12:50746547-50746548 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs558168593 |
chr12:50746578-50746579 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs190186972 |
chr12:50746583-50746584 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs568804579 |
chr12:50746586-50746587 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs371243180 |
chr12:50746619-50746620 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs374440238 |
chr12:50746620-50746621 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs554422576 |
chr12:50746651-50746652 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs181694910 |
chr12:50746655-50746656 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|